839673-52-8
Chemical Structure
Cevoglitazar
Synonym(s): LBM-642
- CAS No.: 839673-52-8
- Formula:C27H21F3N2O6S
- Molecular Weight:558.53
IUPAC Name: (R)-1-((4-((5-methyl-2-(4-(trifluoromethyl)phenyl)oxazol-4-yl)methoxy)phenyl)sulfonyl)indoline-2-carboxylic acid
InChIKey: KVVODNUBDFULSC-XMMPIXPASA-N
SMILES: O=C([C@@H]1N(S(=O)(C2=CC=C(OCC3=C(C)OC(C4=CC=C(C(F)(F)F)C=C4)=N3)C=C2)=O)C5=C(C=CC=C5)C1)O
Biological Activity: Cevoglitazar (LBM-642) is an orally active and highly potent PPARα and PPARγ dual agonist. Cevoglitazar can reduce food intake, body weight, and fasting plasma insulin in obese mice and cynomolgus monkeys. Cevoglitazar has the potential for diabetes and obesity-related disorders research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cevoglitazar | 97.00% | Cevoglitazar (LBM-642) is an orally active and highly potent PPARα and PPARγ dual agonist. Cevoglitazar can reduce food intake, body weight, and fasting plasma insulin in obese mice and cynomolgus monkeys. Cevoglitazar has the potential for diabetes and obesity-related disorders research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
